No connection

Search Results

ADUS vs GLPG

ADUS
Addus HomeCare Corporation
NEUTRAL
Price
$101.35
Market Cap
$1.88B
Sector
Healthcare
AI Confidence
78%
GLPG
Galapagos NV
NEUTRAL
Price
$28.56
Market Cap
$1.92B
Sector
Healthcare
AI Confidence
80%

Valuation

P/E Ratio
ADUS
19.42
GLPG
5.16
Forward P/E
ADUS
13.61
GLPG
-18.18
P/B Ratio
ADUS
1.69
GLPG
0.5
P/S Ratio
ADUS
1.32
GLPG
1.72
EV/EBITDA
ADUS
12.34
GLPG
-1.95

Profitability

Gross Margin
ADUS
32.47%
GLPG
56.02%
Operating Margin
ADUS
11.25%
GLPG
88.0%
Profit Margin
ADUS
6.74%
GLPG
28.85%
ROE
ADUS
9.33%
GLPG
10.42%
ROA
ADUS
6.13%
GLPG
8.87%

Growth

Revenue Growth
ADUS
25.6%
GLPG
1093.2%
Earnings Growth
ADUS
52.1%
GLPG
3036.0%

Financial Health

Debt/Equity
ADUS
0.16
GLPG
0.0
Current Ratio
ADUS
1.8
GLPG
20.14
Quick Ratio
ADUS
1.63
GLPG
19.96

Dividends

Dividend Yield
ADUS
--
GLPG
--
Payout Ratio
ADUS
0.0%
GLPG
0.0%

AI Verdict

ADUS NEUTRAL

ADUS exhibits mixed financial health with a Piotroski F-Score of 4/9, indicating a weak to stable foundation, and no Altman Z-Score available, which limits distress risk assessment. The stock trades at $101.35, below its intrinsic value of $153.99 and Graham Number of $83.83, suggesting potential undervaluation on a defensive basis. However, strong revenue and earnings growth (25.6% and 52.1% YoY) are tempered by bearish insider activity and a lack of dividend. Analysts maintain a 'buy' recommendation with a target of $140.23, reflecting optimism in future performance.

Strengths
Strong earnings growth of 52.1% YoY and 52.5% Q/Q
High revenue growth of 25.6% YoY, outpacing sector average
Attractive intrinsic value of $153.99, implying upside potential
Risks
Piotroski F-Score of 4/9 indicates weak financial strength and limited operational efficiency
Bearish insider sentiment with 19 sell transactions and $2.99M in sales over 6 months
No dividend and zero payout ratio, limiting income appeal
GLPG NEUTRAL

GLPG presents a classic 'value trap' profile: while the Graham Number ($84.09) and Intrinsic Value ($163.14) suggest massive undervaluation, the Piotroski F-Score of 2/9 indicates severely weak fundamental health. The company boasts a pristine balance sheet with zero debt and an extraordinary current ratio of 20.14, yet the market is pricing it at a 66% discount to its defensive fair value. This discrepancy, combined with a negative forward P/E and a 0/100 technical trend, suggests the market anticipates a significant reversal of recent growth spikes.

Strengths
Zero debt (Debt/Equity: 0.00)
Extreme short-term liquidity (Current Ratio: 20.14)
Deeply undervalued relative to book value (P/B: 0.50)
Risks
Weak fundamental trend (Piotroski F-Score: 2/9)
Negative forward earnings expectations (Forward P/E: -18.18)
Strong bearish technical momentum (Technical Trend: 0/100)

Compare Another Pair

ADUS vs GLPG: Head-to-Head Comparison

This page compares Addus HomeCare Corporation (ADUS) and Galapagos NV (GLPG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile